Emergent Biosolutions, Inc. Share Price

Emergent Biosolutions, Inc. Share Price

NYSE: EBS | Small Cap
$5.62
-$0.18 (-3.19%) Last updated on 18 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Emergent Biosolutions, Inc. Stock Performance

Open
$5.78
Prev. Close
$5.80
Circuit Range
N/A
Day Range
$5.57 - $5.87
Year Range
$4.37 - $14.04
Volume
52,669
Average Traded
$5.64

Emergent Biosolutions, Inc. Share Price Today

As of 18 November 2026, Emergent Biosolutions, Inc.'s share price is $5.62. The stock opened at $5.78, compared to its previous close of $5.80. During today's trading session, Emergent Biosolutions, Inc.'s share price traded between $5.57 and $5.87, with an average price of $5.72. Over the past 52 weeks, the stock has recorded a high of $14.04 and a low of $4.37. In terms of performance, Emergent Biosolutions, Inc.'s share price has declined by 38.34% over the last six months and is down 49.82% on a year-on-year basis.

Emergent Biosolutions, Inc. Share Price Chart

Line chart of the Emergent Biosolutions, Inc. price trend over the selected period. The price fell overall, ranging from 5.54 to 5.87, ending at 5.62.
$5.57$5.87
L
Show Current Price
H

Emergent Biosolutions, Inc. Stock Fundamentals & Key Indicators

Market Cap
$300.67M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-5.07
Revenue (TTM)
$742.90B
Return On Equity (TTM)
-83.24%
Profit Margin
7.08%
Debt to Equity
1.62
Quarterly Earnings Growth YoY
40.11%

Emergent Biosolutions, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$148.70$156.10$234.30$110.00
Net Profit-$54.60$6.80-$180.20-$32.70
Net Profit Margin-36.72%4.36%-76.91%-29.73%
Income ChangeN/A112.45%-2750.00%81.85%

Emergent Biosolutions, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$1117.50$1049.30$1043.60$742.90
Net Profit-$211.60-$760.50-$190.60$52.60
Net Profit Margin-18.94%-72.48%-18.26%7.08%
Income ChangeN/A-259.40%74.94%127.60%

About Emergent Biosolutions, Inc.

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.

Emergent Biosolutions, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$6.76
$5.63
-17.08%
Oct 2026
$6.54
$6.79
+2.80%
Sep 2026
$6.21
$6.61
+11.57%
Aug 2026
$7.32
$5.92
-18.01%
Jul 2026
$8.39
$7.22
-14.00%
Jun 2026
$8.82
$8.39
-7.90%
May 2026
$8.97
$9.12
+9.82%
Apr 2026
$8.40
$8.30
+0.06%
Mar 2026
$7.93
$8.29
+1.97%
Feb 2026
$11.31
$8.13
-28.26%
Jan 2026
$12.23
$11.34
-8.18%
Dec 2025
$10.96
$12.35
+10.27%

EBS Share Price FAQs